Former Sanofi Exec Bill Sibold Appointed as Madrigal's New CEO
Madrigal Pharmaceuticals has announced the appointment of former Sanofi executive Bill Sibold as its new CEO, succeeding Paul Friedman, who will remain on the company's board of directors. Sibold previously served as the executive vice president of specialty care at Sanofi, overseeing significant growth and the launch of the blockbuster dermatology product Dupixent.